%0 Journal Article
%T Incidence of induced abortion among commercially insured pregnant patients with cancer.
%A Swartz JJ
%A Huang Y
%A Wu J
%A Moss H
%A Hershman DL
%A Wright JD
%J Contraception
%V 0
%N 0
%D 2024 Jun 4
%M 38844202
%F 3.051
%R 10.1016/j.contraception.2024.110511
%X <B>OBJECTIVE: </B>This study aimed to characterize pregnancy outcomes and the incidence of induced abortion among pregnant people with a diagnosis of malignancy.<BR><B>METHODS: </B>We conducted a retrospective cohort study among privately insured people aged 12 to 55 years from the fourth quarter of 2015-2020 using US claims data from Merative MarketScan Research Databases. We included pregnancies from seven states with favorable policies for private insurance coverage of abortion.<BR><B>RESULTS: </B>There were 1471 of 183,685 (0.8%) pregnancies with a cancer diagnosis. Among those receiving anticancer therapy, 21.6% (95% CI: 14.4-30.4%) underwent induced abortion compared with 10.9% (95% CI: 10.8-11.1%) of pregnant patients without a cancer diagnosis.<BR><B>CONCLUSIONS: </B>Abortion restrictions may affect many pregnant women requiring cancer treatment in early pregnancy.